Medical News |
- Methadone treatment halves HIV risk
- Lenalidomide worsens survival, adverse events in prostate cancer
- Further evidence against sun bed use
| Methadone treatment halves HIV risk Posted: 11 Oct 2012 05:00 PM PDT Methadone substitution can significantly reduce the risk for HIV transmission among people who inject opiate drugs, says a team of international researchers. |
| Lenalidomide worsens survival, adverse events in prostate cancer Posted: 11 Oct 2012 05:00 PM PDT A combination of lenalidomide plus docetaxel and prednisone treatment in patients with chemotherapy-naive prostate cancer leads to worse overall survival rates and increased toxicity compared with placebo, show study results. |
| Further evidence against sun bed use Posted: 11 Oct 2012 05:00 PM PDT Results from a systematic review and meta-analysis published in the BMJ confirm those from previous studies linking sun bed use with an increased risk for skin cancer. |
| You are subscribed to email updates from MedWire Medical News Combined Feed To stop receiving these emails, you may unsubscribe now. | Email delivery powered by Google |
| Google Inc., 20 West Kinzie, Chicago IL USA 60610 | |
No comments:
Post a Comment